5 things to watch on the ASX 200 next week

Mesoblast limited (ASX:MSB) and tech shares will be on watch on the ASX 200 next week. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A very strong finish on Friday led to the S&P/ASX 200 Index (ASX: XJO) charging notably higher last week. The benchmark index climbed 1.7% over the period to end it at 5,964.9 points.

Another busy five days is expected next week. To keep you informed, I have picked out five things to watch:

Lab technician analyses a sample in a laboratory for a clinical trial

Image source: Getty Images

ASX futures pointing higher.

The latest SPI futures are pointing to the ASX 200 opening the week 21 points higher on Monday. This follows a very positive end to the week on Wall Street. On Friday night the Dow Jones rose 1.3%, the S&P 500 climbed 1.6%, and the Nasdaq stormed a sizeable 2.25% higher. The latter could be good news for tech shares such as Afterpay Ltd (ASX: APT) and Xero Limited (ASX: XRO).

Annual general meeting season kicks off.

This week is the start of annual general meeting (AGM) season. As most companies traditionally provide trading updates at these meetings, investors should soon be able to gain an insight into how different sides of the economy are performing during the pandemic. Holding an AGM next will be stock exchange operator ASX Ltd (ASX: ASX) on Wednesday.

Mesoblast remestemcel-L FDA decision.

The Mesoblast limited (ASX: MSB) share price will be on watch next week. Last month the Oncologic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) voted that the available data supports the efficacy of its remestemcel-L (RYONCIL) product in paediatric patients with steroid-refractory acute graft versus host disease. A final decision will be made by the FDA in the United States on Wednesday evening (Australia time). If approved, Mesoblast plans to launch RYONCIL in the United States in 2020.

Shares going ex-dividend.

A number of shares are due to go ex-dividend next week and could trade lower. This includes mining services company NRW Holdings Limited (ASX: NWH) on Monday, property company Cromwell Property Group (ASX: CMW) on Tuesday, and Perenti Global Ltd (ASX: PRN) on Friday.

Billions of dollars of dividends on the way.

It is going to be a bumper week of dividend payments for Australian investors. A large number of companies are due to pay their dividends over the next five days. This includes dividend favourites such as banking giants Australia and New Zealand Banking GrpLtd (ASX: ANZ) and Commonwealth Bank of Australia (ASX: CBA) on Wednesday. Elsewhere, supermarket operator Coles Group Ltd (ASX: COL) is paying its dividend on Tuesday and iron ore producer Fortescue Metals Group Limited (ASX: FMG) is rewarding its shareholders on Friday.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of AFTERPAY T FPO and COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, South32, and Westpac shares

Analysts have given their verdict on these popular shares.

Read more »

Woman with a scared look has hands on her face.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: ANZ, Breville, and Macquarie shares

Is Morgans bullish or bearish on these shares in April? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »